216 related articles for article (PubMed ID: 3728337)
1. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
Liem LB; Clay DA; Franz MR; Swerdlow CD
Am Heart J; 1987 Jun; 113(6):1390-6. PubMed ID: 3591608
[TBL] [Abstract][Full Text] [Related]
4. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
[TBL] [Abstract][Full Text] [Related]
6. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
7. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease.
Garan H; Stavens CS; McGovern B; Kelly E; Ruskin JN
Am J Cardiol; 1986 Nov; 58(10):977-80. PubMed ID: 3776854
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic actions of pirmenol in dogs with recent myocardial infarction.
Lynch JJ; DiCarlo LA; Montgomery DG; Hassan T; Lucchesi BR
Am Heart J; 1986 Oct; 112(4):752-8. PubMed ID: 3766375
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease.
Friehling TD; Lipshutz H; Marinchak RA; Stohler JL; Kowey PR
Am J Cardiol; 1990 Jun; 65(20):1328-33. PubMed ID: 2343820
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiological anti-arrhythmia effects of tiracizine in ventricular tachycardia].
Volkmann H; Kühnert H; Dannberg G; Heinke M; Leeder U; Popp U
Z Gesamte Inn Med; 1991 Dec; 46(17):635-41. PubMed ID: 1776306
[TBL] [Abstract][Full Text] [Related]
17. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
[TBL] [Abstract][Full Text] [Related]
18. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.
Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE
Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
[TBL] [Abstract][Full Text] [Related]
20. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
